|
|
Urinary Bladder, Overactive (Latest Articles)
Latest indexed articles for 'Urinary Bladder, Overactive'
Articles 1 to 10 of 200:
29 Sep 2009
rec_pub_19773008-successful-treatment-hydrodistension-boy-refractory-overactive.htm
Prostanoid receptor subtypes: new targets for OAB drugs?
14 Sep 2009
rec_pub_19758658-prostanoid-receptor-subtypes-new-targets-oab-drugs.htm
Solifenacin for overactive bladder: patient-reported outcomes from a large placebo-controlled trial.
30 Aug 2009
OBJECTIVE: Overactive bladder (OAB) is a prevalent, chronic condition that can negatively affect health-related quality of life (HRQL). Treatment goals are to improve symptoms and HRQL. We assessed the efficacy of solifenacin in OAB patients using ...
rec_pub_19820284-solifenacin-overactive-bladder-patient-reported-outcomes-large.htm
18 Aug 2009
rec_pub_19695638-editorial-comment.htm
Double anticholinergic therapy for refractory overactive bladder.
18 Aug 2009
PURPOSE: Using 2 anticholinergic medications simultaneously (10 to 30 mg oxybutynin, 4 mg tolterodine and/or 5 to 10 mg solifenacin) we optimized the medical therapy for children in whom single agent anticholinergic therapy failed. We evaluated ...
rec_pub_19695628-double-anticholinergic-therapy-refractory-overactive-bladder.htm
18 Aug 2009
rec_pub_19695627-editorial-comment.htm
18 Aug 2009
rec_pub_19695626-editorial-comment.htm
18 Aug 2009
rec_pub_19695625-editorial-comment.htm
24-hour rectal manometry for overactive bladder.
18 Aug 2009
PURPOSE: We describe prolonged rectal manometry used to characterize rectal motor activity patterns and possible rectum-bladder interaction during defecation and micturition in children with nonneuropathic overactive bladder. MATERIALS AND METHODS: ...
rec_pub_19695617-24-hour-rectal-manometry-overactive-bladder.htm
Solifenacin for therapy resistant overactive bladder.
18 Aug 2009
PURPOSE: With the availability of the once daily oral antimuscarinic agent solifenacin (5 mg), we started to use it for therapy resistant overactive bladder. We evaluate side effects and efficacy. MATERIAL AND METHODS: We reviewed the charts of ...
rec_pub_19695608-solifenacin-therapy-resistant-overactive-bladder.htm
Results: [1-10] [11-20] [21-30] [31-40] [41-50] [51-60] [61-70] [71-80] [81-90] [91-100] [101-110] [111-120] [121-130] [131-140] [141-150] [151-160] [161-170] [171-180] [181-190] [191-200]